You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 283 No. 17, May 3, 2000 TABLE OF CONTENTS
  JAMA
  •  Online Features
  From the Food and Drug Administration
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bacterial Contamination Alert

JAMA. 2000;283:2228.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The FDA has announced that Clinipad Corp of Rocky Hill, Conn, is voluntarily recalling antiseptic sterile skin preparations because of confirmed bacterial contamination in some lots.

The recall of the Clinipad sterile products includes povidone iodine, tincture of iodine, benzoin tincture, acetone alcohol and alcohol antiseptic products, and Sterile Cliniguard Protective Dressing manufactured since January 1, 1997. The recalled products have been distributed under the names Cliniswab, Clinipad, Clinidine, Cliniguard, EZ Prep, Steri Wipe, Cooper Instrument Corp, Moore Medial Corp, and Rauscher. All products with lot numbers beginning with 7, 8, 9, or 0, and labeled as "sterile" should be destroyed.

The FDA has posted at http://www.fda.gov/cber/infosheets.htm information on methods and products that may be used for arm preparation prior to the collection of blood and blood components. Additional information is at http://www.fda.gov/medwatch/safety/2000/safety00.htm.

Questions regarding this alert may be e-mailed to phann@cdrh.fda.gov, faxed to Marian Zellner at (301) . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Improving Laboratory Monitoring at Initiation of Drug Therapy in Ambulatory Care: A Randomized Trial
Raebel et al.
Arch Intern Med 2005;165:2395-2401.
ABSTRACT | FULL TEXT  

A Cohort Study of the Incidence of Serious Acute Liver Injury in Diabetic Patients Treated With Hypoglycemic Agents
Chan et al.
Arch Intern Med 2003;163:728-734.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.